| 000 | 01867 a2200601 4500 | ||
|---|---|---|---|
| 005 | 20250516013922.0 | ||
| 264 | 0 | _c20110211 | |
| 008 | 201102s 0 0 eng d | ||
| 022 | _a1096-8652 | ||
| 024 | 7 |
_a10.1002/ajh.21912 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBerenson, James R | |
| 245 | 0 | 0 |
_aPrognostic factors and jaw and renal complications among multiple myeloma patients treated with zoledronic acid. _h[electronic resource] |
| 260 |
_bAmerican journal of hematology _cJan 2011 |
||
| 300 |
_a25-30 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aDiphosphonates _xadverse effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImidazoles _xadverse effects |
| 650 | 0 | 4 |
_aJaw Diseases _xchemically induced |
| 650 | 0 | 4 |
_aKidney Diseases _xchemically induced |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMultiple Myeloma _xdrug therapy |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aZoledronic Acid |
| 700 | 1 | _aYellin, Ori | |
| 700 | 1 | _aCrowley, John | |
| 700 | 1 | _aMakary, Adel | |
| 700 | 1 | _aGravenor, Donald S | |
| 700 | 1 | _aYang, Hank H | |
| 700 | 1 | _aUpadhyaya, Gargi H | |
| 700 | 1 | _aFlinn, Ian W | |
| 700 | 1 | _aStaszewski, Harry | |
| 700 | 1 | _aTiffany, Natasha M | |
| 700 | 1 | _aSanani, Shamel | |
| 700 | 1 | _aFarber, Charles M | |
| 700 | 1 | _aMorganstein, Neil | |
| 700 | 1 | _aBolejack, Vanessa | |
| 700 | 1 | _aNassir, Youram | |
| 700 | 1 | _aHilger, James D | |
| 700 | 1 | _aSefaradi, Ashkan | |
| 700 | 1 | _aShamouelian, Albert | |
| 700 | 1 | _aSwift, Regina A | |
| 773 | 0 |
_tAmerican journal of hematology _gvol. 86 _gno. 1 _gp. 25-30 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/ajh.21912 _zAvailable from publisher's website |
| 999 |
_c20412942 _d20412942 |
||